NASDAQ:CELC - Celcuity Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $23.75 +0.16 (+0.68 %) (As of 02/22/2019 04:00 PM ET)Previous Close$23.75Today's Range$22.9743 - $23.7552-Week Range$13.16 - $31.00Volume2,920 shsAverage Volume5,324 shsMarket Capitalization$241.30 millionP/E Ratio-30.45Dividend YieldN/ABeta0.29 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Celcuity Inc., a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the response rates of cancer patients treated with targeted therapies in the United States. The company is developing CELx tests to diagnose two new sub-types of HER2-negative breast cancer. It is also developing CELx tests to diagnose 14 new potential cancer sub-types in breast, lung, colon, ovarian, kidney, bladder, and hematological cancers. The company was founded in 2012 and is headquartered in Minneapolis, Minnesota. Receive CELC News and Ratings via Email Sign-up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CELC Previous Symbol CUSIPN/A CIK1603454 Webwww.celcuity.com Phone763-392-0767Debt Debt-to-Equity RatioN/A Current Ratio24.13 Quick Ratio24.13Price-To-Earnings Trailing P/E Ratio-30.45 Forward P/E Ratio-31.25 P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$3.11 per share Price / Book7.64Profitability EPS (Most Recent Fiscal Year)($0.78) Net Income$-6,250,000.00 Net MarginsN/A Return on Equity-24.34% Return on Assets-23.67%Miscellaneous Employees22 Outstanding Shares10,160,000Market Cap$241.30 million Next Earnings Date2/26/2019 (Confirmed) OptionableNot Optionable Celcuity (NASDAQ:CELC) Frequently Asked Questions What is Celcuity's stock symbol? Celcuity trades on the NASDAQ under the ticker symbol "CELC." How were Celcuity's earnings last quarter? Celcuity Inc (NASDAQ:CELC) announced its quarterly earnings results on Thursday, August, 9th. The company reported ($0.15) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.17) by $0.02. View Celcuity's Earnings History. When is Celcuity's next earnings date? Celcuity is scheduled to release their next quarterly earnings announcement on Tuesday, February 26th 2019. View Earnings Estimates for Celcuity. What price target have analysts set for CELC? 2 analysts have issued 1 year target prices for Celcuity's stock. Their forecasts range from $35.00 to $36.00. On average, they expect Celcuity's share price to reach $35.50 in the next twelve months. This suggests a possible upside of 49.5% from the stock's current price. View Analyst Price Targets for Celcuity. What is the consensus analysts' recommendation for Celcuity? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Celcuity in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Celcuity. Has Celcuity been receiving favorable news coverage? News stories about CELC stock have trended somewhat positive this week, according to InfoTrie. The research firm scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Celcuity earned a news impact score of 1.7 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near term. Who are some of Celcuity's key competitors? Some companies that are related to Celcuity include Veracyte (VCYT), RadNet (RDNT), Enzo Biochem (ENZ), Psychemedics (PMD), PotNetwork (POTN), Miragen Therapeutics (MGEN), Fulgent Genetics (FLGT), First Choice Healthcare Solutions (FCHS), OpGen (OPGN), CBA Florida (CBAI), Cancer Genetics (CGIX), Aeon Global Health (AGHC), Biocept (BIOC) and Foundation Medicine (FMI). What other stocks do shareholders of Celcuity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Celcuity investors own include Amicus Therapeutics (FOLD), New Residential Investment (NRZ), Allena Pharmaceuticals (ALNA), DDR (DDR), Rockwell Medical (RMTI), Axovant Sciences (AXON), Ocular Therapeutix (OCUL), Corbus Pharmaceuticals (CRBP), Madrigal Pharmaceuticals (MDGL) and Genocea Biosciences (GNCA). Who are Celcuity's key executives? Celcuity's management team includes the folowing people: Mr. Brian F. Sullivan, Co-Founder, Chairman, CEO & CFO (Age 56)Dr. Lance G. Laing, Co-Founder, Chief Science Officer, VP, Sec. & Director (Age 56)Ms. Vicky Hahne, Chief Financial Officer (Age 52)Ms. Laura Beggrow RN, Chief Commercial Officer (Age 55)Mr. Larry Fitzgerald, VP of Strategic Partnerships & Managed Markets (Age 47) When did Celcuity IPO? (CELC) raised $18 million in an IPO on Wednesday, September 20th 2017. The company issued 2,000,000 shares at $8.00-$10.00 per share. Craig-Hallum Capital Group served as the underwriter for the IPO. Who are Celcuity's major shareholders? Celcuity's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (2.84%), Gagnon Securities LLC (1.72%), ARS Investment Partners LLC (0.70%), Northern Trust Corp (0.61%), Geode Capital Management LLC (0.34%) and Accredited Investors Inc. (0.24%). View Institutional Ownership Trends for Celcuity. Which institutional investors are selling Celcuity stock? CELC stock was sold by a variety of institutional investors in the last quarter, including Gagnon Securities LLC, BlackRock Inc., Accredited Investors Inc. and SNS Financial Group LLC. View Insider Buying and Selling for Celcuity. Which institutional investors are buying Celcuity stock? CELC stock was purchased by a variety of institutional investors in the last quarter, including ARS Investment Partners LLC, JNBA Financial Advisors, Kessler Investment Group LLC, Geode Capital Management LLC, Northern Trust Corp and Strs Ohio. View Insider Buying and Selling for Celcuity. How do I buy shares of Celcuity? Shares of CELC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Celcuity's stock price today? One share of CELC stock can currently be purchased for approximately $23.75. How big of a company is Celcuity? Celcuity has a market capitalization of $241.30 million. The company earns $-6,250,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis. Celcuity employs 22 workers across the globe. What is Celcuity's official website? The official website for Celcuity is http://www.celcuity.com. How can I contact Celcuity? Celcuity's mailing address is 16305 36TH AVENUE N SUITE 450, MINNEAPOLIS MN, 55446. The company can be reached via phone at 763-392-0767. MarketBeat Community Rating for Celcuity (NASDAQ CELC)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 176 (Vote Outperform)Underperform Votes: 182 (Vote Underperform)Total Votes: 358MarketBeat's community ratings are surveys of what our community members think about Celcuity and other stocks. Vote "Outperform" if you believe CELC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CELC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2019 by MarketBeat.com StaffFeatured Article: What are no-load funds?